US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

DARE Dare Bioscience Inc

0.31

0.0029 (0.94%)

Última actualización: 14:34:41

Retrasado por 15 minutos

Form 3 - Initial statement of beneficial ownership of securities

Dare Bioscience (NASDAQ:DARE)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Dare Bioscience.

Dare Bioscience (NASDAQ:DARE)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Dare Bioscience.

Noticias sobre Dare Bioscience Inc DARE

Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and Webcast on May 14, 2024
Martes 7 de Mayo 2024 (2 días hace) • GlobeNewswire Inc.

Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
Jueves 2 de Mayo 2024 (1 semana hace) • GlobeNewswire Inc.

Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts
Martes 30 de Abril 2024 (1 semana hace) • GlobeNewswire Inc.

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
Martes 23 de Abril 2024 (2 semanas hace) • GlobeNewswire Inc.

Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Jueves 11 de Abril 2024 (4 semanas hace) • GlobeNewswire Inc.

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
Jueves 28 de Marzo 2024 (1 mes hace) • GlobeNewswire Inc.

US Stock Futures Stable in Pre-Market On Path for Consecutive Quarterly Gains, Oil Prices Rise
Jueves 28 de Marzo 2024 (1 mes hace) • IH Market News

Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024
Jueves 21 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISSWSH) Annual Meeting
Jueves 22 de Febrero 2024 (3 meses hace) • GlobeNewswire Inc.

Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024
Miércoles 31 de Enero 2024 (3 meses hace) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Lunes 29 de Enero 2024 (3 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Viernes 26 de Enero 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Dare Bioscience Inc Artículos de Noticias

Euro vs US Dollar

Bank of America

Health Care Select Sector

Deutsche Telekom (QX)

JP Morgan Chase

BNP Paribas (QX)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones